advertisement
 

  Back to News Research News from 2003

Research News From 2003

  1. Transmission of Maternal Islet Antibodies and Risk of Autoimmune Diabetes in Offspring of Mothers With Type 1 Diabetes. Free full text available. (28 December 2003)
  2. Transplantation of Reversibly Immortalized Insulin-Secreting Human Hepatocytes Controls Diabetes in Pancreatectomized Pigs. (28 December 2003)
  3. Association of autoantibody and cytokines with latent autoimmune diabetes in adults. (28 December 2003)
  4. Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus. (28 December 2003)
  5. Low Synthesis and High Absorption of Cholesterol Characterize Type 1 Diabetes. (28 December 2003)
  6. Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes. (28 December 2003)
  7. Intensive Therapy With Inhaled Insulin via the AERx Insulin Diabetes Management System. (28 December 2003)
  8. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. (28 December 2003)
  9. Favorable Effects of Pioglitazone and Metformin Compared With Gliclazide on Lipoprotein Subfractions in Overweight Patients With Early Type 2 Diabetes. (28 December 2003)
  10. Vaccinations May Induce Diabetes-Related Autoantibodies in One-Year-Old Children. (21 December 2003)
  11. Dietary microbial toxins and type 1 diabetes. (21 December 2003)
  12. Can Enteroviruses Cause Type 1 Diabetes? (21 December 2003)
  13. Cow-Milk-Free Diet during Last Trimester of Pregnancy Does Not Influence Diabetes-Related Autoantibodies in Nondiabetic Children. (21 December 2003)
  14. Immunogenetics/Immunopathogenesis of Type 1A Diabetes. (21 December 2003)
  15. Islet Cell Autoimmunity and Transplantation Tolerance: Two Distinct Mechanisms? (21 December 2003)
  16. Reduced thymic expression of islet antigen contributes to loss of self-tolerance. (21 December 2003)
  17. Lung function in children with diabetes mellitus. (21 December 2003)
  18. Detection of GAD-reactive CD4+ cells in so-called "type 1B" diabetes. (21 December 2003)
  19. Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. (21 December 2003)
  20. Abnormal Peripheral Blood Dendritic Cell Populations in Type 1 Diabetes. (21 December 2003)
  21. Insulin resistance in latent autoimmune diabetes of adulthood. (21 December 2003)
  22. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. (21 December 2003)
  23. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a phase I/II clinical trial. (21 December 2003)
  24. Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients. (21 December 2003)
  25. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. (14 December 2003)
  26. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. (14 December 2003)
  27. Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus. (14 December 2003)
  28. Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments. (14 December 2003)
  29. Islet Cell Transplantation Associated with Severe Complications, Often Imperfect Glycaemia Control. (14 December 2003)
  30. Researchers Look To Stem Cell Therapy And Bone Marrow Transplants To Find A Cure For Diabetes. See also Stem Cells 101 from the American Society of Hematology annual meeting. (14 December 2003)
  31. Scientists discover connection between obesity and diabetes. See also Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. (14 December 2003)
  32. Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: A pooled post hoc analysis. (14 December 2003)
  33. Survival After Pancreas Transplantation in Patients With Diabetes and Preserved Kidney Function concludes that "... survival for those with diabetes and preserved kidney function and receiving a solitary pancreas transplant was significantly worse compared with the survival of waiting-list patients receiving conventional therapy." See also Study Finds Pancreas Transplants Riskier. (7 December 2003)
  34. A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes. (7 December 2003)
  35. Congenital Heart Disease in Infants of Diabetic Mothers: Echocardiographic Study. (7 December 2003)
  36. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. (7 December 2003)
  37. Is Diabetes Mellitus a Cardiovascular Disease Risk Equivalent for Fatal Stroke in Women?: Data From the Women's Pooling Project. (7 December 2003)
  38. You can listen to a very interesting interview with Dr. Denis Faustman, director of the Massachusetts General Hospital Immunobiology Laboratory, whose team succeeded in curing autoimmune diabetes in mice using spleen cells (click on Talk of the Nation audio). The radio show was live on November 21, 2003. See also Regeneration Of Insulin-producing Islets May Lead To Diabetes Cure, Breakthrough sparks diabetes hope and Researchers Cure Diabetes in Mice for reports of this research in the popular press. (We reported extensively about this study in the What's New from 16 November 2003.) (30 November 2003)
  39. Why Can't We Prevent Type 1 Diabetes? (23 November 2003)
  40. Serum IgG levels to bovine insulin in type I diabetes mellitus. (23 November 2003)
  41. Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. (23 November 2003)
  42. Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression. (23 November 2003)
  43. In Utero Dietary Exposures and Risk of Islet Autoimmunity in Children. (23 November 2003)
  44. Nephrinuria in Diabetic Nephropathy of Type 1 Diabetes. (23 November 2003)
  45. Diagnosis of the metabolic syndrome in children. (23 November 2003)
  46. Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy? (23 November 2003)
  47. Statins for Everybody? New Evidence on the Efficacy and Safety of the Inhibitors of HMG Co-A Reductase. (23 November 2003)
  48. Scientists from Massachusetts General Hospital find new way to reverse autoimmune diabetes in mice. See also Mass General Center for Diabetes Research, New Research Uncovers Potential Cure for Type 1 Diabetes: Islet Regeneration May Now Be Possible, According to Iacocca Foundation, Juvenile diabetes cured in lab mice, and New Research Uncovers Potential Cure For Type 1 Diabetes: Islet Regeneration May Now Be Possible from the Iacocca Foundation. Also see PubMed citation. Interested parties can attend a briefing on this research by Dr. Denise Faustman, Associate Professor of Medicine at Harvard Medical School, Director of the Immunobiology Lab at Massachusetts General Hospital on Thursday December 4, 2003 from 7:00 pm to 9:30 pm in Darien, Connecticut. (16 November 2003)
  49. Treatment of Type 1 Diabetes With Anti-CD3 Monoclonal Antibody: Induction of Immune Regulation? (16 November 2003)
  50. Effects of two pediatric vaccines on autoimmune diabetes in NOD female mice. (16 November 2003)
  51. Insulin Autoantibody Isotypes during the Prediabetic Process in Young Children with Increased Genetic Risk of Type 1 Diabetes. (16 November 2003)
  52. Alternative routes of insulin delivery. (16 November 2003)
  53. Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. (16 November 2003)
  54. Retinal Vascular Changes and 20-Year Incidence of Lower Extremity Amputations in a Cohort With Diabetes. (16 November 2003)
  55. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. (16 November 2003)
  56. Miracle in Mexico reports on the controversial xenotransplantation work performed by Dr. Rafael Valdes in Mexico City to cure type 1 diabetes in teens using porcine islets. See also Doctor criticized for experimental diabetes care and Xenotransplantation Laboratory for more information. (16 November 2003)
  57. We report on the Diabetes Technology Meeting, held November 6-8, 2003 in San Francisco. (9 November 2003)
  58. Gender Differences in Memory and Learning in Children with Insulin-Dependent Diabetes Mellitus (IDDM) over a 4-year Follow-up Interval. (9 November 2003)
  59. Autoimmune thyroid dysfunction in children with type 1 diabetes mellitus: screening guidelines based on a retrospective analysis. (9 November 2003)
  60. Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age. (9 November 2003)
  61. Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and beta-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes. (9 November 2003)
  62. Capnometry for noninvasive continuous monitoring of metabolic status in pediatric diabetic ketoacidosis. (9 November 2003)
  63. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. (2 November 2003)
  64. Association of Solute Carrier Family 12 (Sodium/Chloride) Member 3 With Diabetic Nephropathy, Identified by Genome-Wide Analyses of Single Nucleotide Polymorphisms. (2 November 2003)
  65. We report on the Fourth Annual Research Update of the Diabetes Research Institute. (26 October 2003)
  66. Islet transplantation: immunological perspectives. (26 October 2003)
  67. Symptoms of Common Maternal Infections in Pregnancy and Risk of Islet Autoimmunity in Early Childhood. (26 October 2003)
  68. Identification of a beta-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes. (26 October 2003)
  69. Counterregulatory Hormone and Symptom Responses to Insulin-Induced Hypoglycemia in the Postprandial State in Humans. (26 October 2003)
  70. The relationship between insulin-dependent diabetes mellitus and acute infections in children. (26 October 2003)
  71. Prevalence of Delayed Gastric Emptying in Diabetic Patients and Relationship to Dyspeptic Symptoms. (26 October 2003)
  72. Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: a Role for Insulin Resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. (26 October 2003)
  73. Rapamycin Has a Deleterious Effect on MIN-6 Cells and Rat and Human Islets. (26 October 2003)
  74. Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age. (26 October 2003)
  75. Complications in Young Adults With Early-Onset Type 2 Diabetes: Losing the relative protection of youth. (26 October 2003)
  76. Level of an Advanced Glycated End Product Is Genetically Determined. (19 October 2003)
  77. Young and Elderly Type 2 Diabetic Patients Inhaling Insulin with the AERx(R) Insulin Diabetes Management System: A Pharmacokinetic and Pharmacodynamic Comparison. (19 October 2003)
  78. Preventative biology of type 1 diabetes: implications for clinical preventative studies. (19 October 2003)
  79. Chilean study examined examined cow's milk exposure among kids with type 1 diabetes. (19 October 2003)
  80. Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works. (19 October 2003)
  81. ISPAD 2003 Abstracts include an extensive list of studies presented at the recent ISPAD meeting. Abstracts are all PDF files, in which multiple abstracts are presented within each file. Selected abstracts include: (12 October 2003)
    1. Adolescents with type 1 diabetes exhibit cognitive adaptation during prolonged mild hypoglycemia, which notes that "These data provide the first evidence of cognitive adaptation in adolescents during prolonged mild hypoglycemia...."
    2. Which children and adolescents with type 1 diabetes profit from insulin pump therapy?, which notes that "Adolescents with poor glycemic control frequently profit from CSII."
    3. Experience with insulin glargine in children and adolescents with type 1 diabetes: A 6-18 month follow-up study, which notes that "insulin glargine may be associated with better control in paediatric patients with type 1 diabetes, when compared with patients on NPH insulin."
    4. Effect of the addition of metformin to insulin therapy in adolescents and young adults with type 1 diabetes mellitus, which notes that "Metformin is safe and may represent a useful adjunct to management of type 1 diabetes in adolescents and young adults who have poor glycemic control with reduction of insulin dose and body weight."
    5. Evening exercise in adolescents with T1D on MDI or CSII, which notes that "Patients on CSII are less likely to have a hypoglycemic episode after an evening exercise as compared to the night before exercise or to the patients on MDI."
    6. Long-term efficacy of physical activity on metabolic control in type 1 diabetes, which notes that "4 hours/week of exercise can improve long-term metabolic control."
    7. QTc interval prolongation and QTc dispersion in type 1 diabetic children and adolescents, which notes that "QTc prolongation and a larger QTc dispersion are already present in a significant proportion of children and adolescents with diabetes."
    8. The microbiological safety of pig islet xenotransplantation in humans, which notes that "Islet xenotransplantation using islets from neonatal animals from a highly selected herd of pigs is a safe procedure, and shows therapeutic promise."
  82. Description of microangiopathy in children with type 1 diabetes mellitus: a 19-year retrospective study. (12 October 2003)
  83. Acute-phase proteins among patients with type 1 diabetes. (12 October 2003)
  84. Lifetime Risk for Diabetes Mellitus in the United States reports on the growing risk of developing type 2 diabetes for Americans. (12 October 2003)
  85. Bone Is A Target For The Anti-diabetic Compound Rosiglitazone. (12 October 2003)
  86. Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity. (5 October 2003)
  87. Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies. (5 October 2003)
  88. Dietary intake of 10- to 16-year-old children and adolescents in central and northern Europe and association with the incidence of type 1 diabetes. (5 October 2003)
  89. Xenogeneic transplantation of porcine islets: an overview. (5 October 2003)
  90. Description of microangiopathy in children with type 1 diabetes mellitus: a 19-year retrospective study. (5 October 2003)
  91. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? (5 October 2003)
  92. Diabetes Mellitus: Does it Affect Bone? (5 October 2003)
  93. Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose. (28 September 2003)
  94. Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort). (28 September 2003)
  95. Testing the Accelerator Hypothesis: The relationship between body mass and age at diagnosis of type 1 diabetes. (28 September 2003)
  96. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. (28 September 2003)
  97. Evidence for Heterogeneous Pathogenesis of Insulin-Treated Diabetes in Black and White Children. (28 September 2003)
  98. Progression of Coronary Artery Calcification in Type 1 Diabetes: The importance of glycemic control. (28 September 2003)
  99. Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management. (28 September 2003)
  100. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. (28 September 2003)
  101. Tele-Screening for Diabetic Retinopathy With the Retinal Thickness Analyzer. (28 September 2003)
  102. The ultrasound assessment of adipose tissue deposition in fetuses of 'well controlled' insulin-dependent diabetic pregnancies. (28 September 2003)
  103. Sonographic Evaluation of Fetal Growth and Body Composition in Women With Different Degrees of Normal Glucose Metabolism. (28 September 2003)
  104. Encapsulated islets in diabetes treatment.. (28 September 2003)
  105. Dose-Response Relationships of Inhaled Insulin Delivered via the Aerodose Insulin Inhaler and Subcutaneously Injected Insulin in Patients With Type 2 Diabetes. (28 September 2003)
  106. Effects of different durations of breath holding after inhalation of insulin using the AERx((R)) insulin diabetes management system. (28 September 2003)
  107. Research Use of the AIDA www.2aida.org Diabetes Software Simulation Program: A Review-Part 2. Generating Simulated Blood Glucose Data for Prototype Validation. (28 September 2003)
  108. How High Should an ACE Inhibitor or Angiotensin Receptor Blocker Be Dosed in Patients with Diabetic Nephropathy? (21 September 2003)
  109. Is microalbuminuria a risk factor for diabetic retinopathy? (21 September 2003)
  110. Reducing insulin resistance with metformin: the evidence today. (21 September 2003)
  111. Microcirculation in insulin resistance and diabetes: more than just a complication. (21 September 2003)
  112. Improving survival with metformin: the evidence base today. (21 September 2003)
  113. Beneficial effects of metformin on haemostasis and vascular function in man. (21 September 2003)
  114. Do effects on blood pressure contribute to improved clinical outcomes with metformin? (21 September 2003)
  115. Metformin inhibition of glycation processes. (21 September 2003)
  116. The potential of metformin for diabetes prevention. (21 September 2003)
  117. Metformin and vascular protection: a diabetologist's view. (21 September 2003)
  118. Metformin and vascular protection: a cardiologist's view. (21 September 2003)
  119. Placental Pathology in Women with Type 1 Diabetes and in a Control Group with Normal and Large-for-Gestational-Age Infants.. (21 September 2003)
  120. Human Placental Growth Hormone, Insulin-Like Growth Factor I and -II, and Insulin Requirements during Pregnancy in Type 1 Diabetes. (21 September 2003)
  121. The impact of smoking on inhaled insulin. (21 September 2003)
  122. Illness Representations and Coping as Predictors of Emotional Well-being in Adolescents with Type 1 Diabetes. (14 September 2003)
  123. A Meta-Analysis of the Association Between Childhood Type 1 Diabetes and Atopic Disease. (14 September 2003)
  124. Impact of Metabolic Control and Serum Lipids on the Concentration of Advanced Glycation End Products in the Serum of Children and Adolescents With Type 1 Diabetes, as Determined by Fluorescence Spectroscopy and N-(Carboxymethyl)Lysine ELISA. (14 September 2003)
  125. Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. (14 September 2003)
  126. New Insights Into Diabetic Polyneuropathy. See also Researchers find ways to spot early diabetic neuropathy. (14 September 2003)
  127. Urinary F(2)-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. (14 September 2003)
  128. Prevalence of hepatitis A, B, C and E virus in adolescents with type-1 diabetes mellitus. (14 September 2003)
  129. National Surveillance for Type 2 Diabetes Mellitus in Taiwanese Children. (14 September 2003)
  130. Two commonly prescribed diabetes drugs may cause heart failure and fluid buildup, researchers report. See also Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema (in table of contents) and Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.. (14 September 2003)
  131. Abstracts From The International Pancreas And Islet Transplant Association Congress In Dublin, 2003 are online. (7 September 2003)
  132. Inhibition of Food Intake in Obese Subjects by Peptide YY3–36. (7 September 2003)
  133. C-peptide Improves Adenosine-Induced Myocardial Vasodilation in Type 1 Diabetes Patients. (7 September 2003)
  134. C-peptide makes a comeback. (7 September 2003)
  135. Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications. (7 September 2003)
  136. Hemoglobin Glycosylation Index is not related with blood glucose. (7 September 2003)
  137. Thyroid Volume As Measured By Ultrasonography in Patients With Type 1 Diabetes Mellitus without Thyroid Dysfunction. (7 September 2003)
  138. Prevalence of hepatitis A, B, C and E virus in adolescents with type-1 diabetes mellitus. (7 September 2003)
  139. Intranasally administered insulin intended for prevention of type 1 diabetes-a safety study in healthy adults. (7 September 2003)
  140. Vaccine therapies for the prevention of type 1 diabetes mellitus. (7 September 2003)
  141. C-peptide and diabetic neuropathy. (31 August 2003)
  142. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. (31 August 2003)
  143. Percutaneous Transhepatic Pancreatic Islet Cell Transplantation in Type 1 Diabetes Mellitus: Radiologic Aspects. (31 August 2003)
  144. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. (31 August 2003)
  145. Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes. (31 August 2003)
  146. Coxsackie virus B antibodies are increased in HLA DR3-MICA5.1 positive type 1 diabetes patients in the Linkoping region of Sweden. (31 August 2003)
  147. Type 1 Diabetics May Gain Disease Control Through Transdermal Insulin Patch. (31 August 2003)
  148. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. See also Insulin Gene Found Central to Type 1 Diabetes Development in Animal Model. (24 August 2003)
  149. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. (24 August 2003)
  150. Remission and regression of diabetic nephropathy. (24 August 2003)
  151. Environmental risk factors for type 1 diabetes in Rome and province. (24 August 2003)
  152. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine. See also Antipsychotic-induced type 2 diabetes: evidence from a large health plan database. (24 August 2003)
  153. Type 2 and other forms of diabetes in 0–30 year olds: a hospital based study in Leeds, UK. (24 August 2003)
  154. Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. (24 August 2003)
  155. Inhaled insulin in diabetes mellitus. (17 August 2003)
  156. Analysis of DNA Damage Using the Comet Assay in Infants Fed Cow's Milk. (17 August 2003)
  157. Retinopathy in patients with diabetic ophthalmoplegia. (17 August 2003)
  158. Multifunctional microcapsules for pancreatic islet cell entrapment: design, preparation and in vitro characterization. (10 August 2003)
  159. Bio-engineering insulin-secreting cells from embryonic stem cells: a review of progress. (10 August 2003)
  160. Infections and risk of type I diabetes in childhood: a population-based case-control study. (10 August 2003)
  161. Three generations of autoimmune diabetes: an extended family study. (10 August 2003)
  162. Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. (10 August 2003)
  163. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. (3 August 2003)
  164. Induction of Angiogenesis in Omentum with Vascular Endothelial Growth Factor: Influence on the Viability of Encapsulated Rat Pancreatic Islets during Transplantation. (3 August 2003)
  165. Subcutaneous transplantation of macroencapsulated porcine pancreatic endocrine cells normalizes hyperglycemia in diabetic mice. (3 August 2003)
  166. In Vivo Functioning and Transplantable Mature Pancreatic Islet-Like Cell Clusters Differentiated from Embryonic Stem Cell. (3 August 2003)
  167. Clinical islet transplantation. (3 August 2003)
  168. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. (3 August 2003)
  169. Oxidative stress status in patients with diabetes mellitus: relationship to diet. (27 July 2003)
  170. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. (27 July 2003)
  171. Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion. (27 July 2003)
  172. Diabetogenic Potential of Human Pathogens Uncovered in Experimentally Permissive beta-Cells. (27 July 2003)
  173. Environmental risk factors for type 1 diabetes in Rome and province. (27 July 2003)
  174. Differences between males and females in the seasonality of birth and month of clinical onset of disease in children with type 1 diabetes mellitus in Ireland. (27 July 2003)
  175. Host and environmental factors defining the epidemiology of type 1 diabetes mellitus in a group of Lebanese children and young adults. (27 July 2003)
  176. Insulin resistance in newly diagnosed type 1 diabetic children and adolescents. (27 July 2003)
  177. Type 2 and other forms of diabetes in 0-30 year olds: a hospital based study in Leeds, UK. (27 July 2003)
  178. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. (27 July 2003)
  179. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. (27 July 2003)
  180. Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes. (27 July 2003)
  181. Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine. (27 July 2003)
  182. The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations. (27 July 2003)
  183. Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes. (27 July 2003)
  184. Does Low Bone Mineral Density Start in Post-Teenage Years in Women With Type 1 Diabetes? (27 July 2003)
  185. Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial. (27 July 2003)
  186. Development of Early-onset Type 2 Diabetes in the Young: Implications for Child Bearing. (27 July 2003)
  187. The ALLHAT Study. (20 July 2003)
  188. Ketoacidosis at onset of type 1 diabetes mellitus in children – frequency and clinical presentation. (20 July 2003)
  189. Normal hepatic glycogen storage after fasting and feeding in children and adolescents with type 1 diabetes. (20 July 2003)
  190. Carbohydrate-Induced Memory Impairment in Adults With Type 2 Diabetes. (20 July 2003)
  191. The Need for Glycemic Trials in Type 2 Diabetes. (20 July 2003)
  192. Gastric Emptying of Solid and Liquid Meals in Healthy Controls Compared with Long-Term Type-1 Diabetes Mellitus under Optimal Glucose Control.. (20 July 2003)
  193. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. (20 July 2003)
  194. Vitamin d receptor gene polymorphism affects onset pattern of type 1 diabetes. (20 July 2003)
  195. Left Ventricular Systolic and Diastolic Function in Normotensive Type 1 Diabetic Patients With or Without Autonomic Neuropathy. (20 July 2003)
  196. Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes. (20 July 2003)
  197. A New Cell Secreting Insulin. See also Fish insulin discovery a breakthrough in diabetes treatment. (20 July 2003)
  198. Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis. (13 July 2003)
  199. The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus. (13 July 2003)
  200. Blue-on-yellow perimetry versus achromatic perimetry in type 1 diabetes patients without retinopathy. (13 July 2003)
  201. The epidemiology of autoimmune diseases. (13 July 2003)
  202. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications. (6 July 2003)
  203. Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood. (6 July 2003)
  204. Transient hyperopic refractive changes in newly diagnosed juvenile diabetes. (6 July 2003)
  205. High-risk genotype for type 1 diabetes: a new simple microtiter plate-based ELOSA assay. (6 July 2003)
  206. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: A report from the Allegheny county registry. (6 July 2003)
  207. Herbal remedies: renal tragedies.. Also available in PDF format. (6 July 2003)
  208. The NIDDK has released a report on the Type 1 Diabetes Research Special Statutory Funding Program. (29 June 2003)
  209. Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors. (29 June 2003)
  210. Islet transplant: an option for childhood diabetes? (29 June 2003)
  211. Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. (29 June 2003)
  212. Significance of Microalbuminuria in Long-Duration Type 1 Diabetes. (29 June 2003)
  213. Effects of Duration and Age at Onset of Type 1 Diabetes on Preclinical Manifestations of Nephropathy. (29 June 2003)
  214. Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. (29 June 2003)
  215. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. (29 June 2003)
  216. New Study Demonstrates Bone Protein Can Reverse Kidney Failure. See also BMP-7 counteracts TGF-beta-1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury. (29 June 2003)
  217. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. (29 June 2003)
  218. Statins cut cardiovascular events by a quarter in people with diabetes. Also in PDF format. (29 June 2003)
  219. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. (29 June 2003)
  220. Prediction of cardiovascular risk in people with diabetes. (29 June 2003)
  221. Vascular Risk Factors and Markers of Endothelial Function as Determinants of Inflammatory Markers in Type 1 Diabetes. (29 June 2003)
  222. Relationship Between Diurnal Blood Pressure, Renal Hemodynamic Function, and the Renin-Angiotensin System in Type 1 Diabetes. (29 June 2003)
  223. Serum levels of low molecular weight advanced glycation end products in diabetic subjects. (29 June 2003)
  224. Islet cell autoantibodies in cord blood from children with blood group incompatibility or hyperbilirubinemia. (29 June 2003)
  225. No Association between Preeclampsia or Cesarean Section and Incidence of Type 1 Diabetes among Children: A Large, Population-Based Cohort Study. (29 June 2003)
  226. Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes. (29 June 2003)
  227. Oral Insulin Fails to Prevent Type 1 Diabetes. (22 June 2003)
  228. Insulin independence following isolated islet transplantation and single islet infusions. (22 June 2003)
  229. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. See also Influence of glucose control, lipoproteins, and haemostasis function on brachial endothelial reactivity and carotid intima-media area, stiffness and diameter in Type 1 diabetes mellitus patients. (22 June 2003)
  230. Enalapril Shows Renoprotective Effect in Diabetics with Microalbuminuria. (22 June 2003)
  231. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes . See also Researchers Find Clue to Cause of Type 1 Diabetes. (22 June 2003)
  232. Long-term ACE Inhibitor Treatment Promotes Renal Health and Improves Lipid Profiles. (22 June 2003)
  233. The effect of diabetes on sensorineural hearing loss. (22 June 2003)
  234. Atopic eczema in early childhood could be protective against Type 1 diabetes. (22 June 2003)
  235. Reversal of diabetes in monkeys after transplantation. See also the Diabetes Institute for Immunology and Transplantation web site. (22 June 2003)
  236. Autonomic function and autoantibodies to autonomic nervous tissues at follow-up in a cohort of young patients with type 1 diabetes. Effects of serum from diabetic patients on human adrenergic cells.. (22 June 2003)
  237. Diabetic neuropathy in patients with "Latent Autoimmune Diabetes of the Adults" (LADA) compared with patients with type 1 and type 2 diabetes. (22 June 2003)
  238. C-Peptide Increases Forearm Blood Flow in Patients with Type 1 Diabetes via a Nitric Oxide-Dependent Mechanism. (22 June 2003)
  239. The Scientist, a news journal for life scientists, has a nice illustration of the potential sources of adult stem cells. (22 June 2003)
  240. Diabetes in the Young: A Paediatric and Epidemiological Perspective by Gy. Soltész is a video presentation of the Somogyi Lecture at the recent annual meeting of EASD. (15 June 2003)
  241. Research study seeks patients diagnosed with type 1 diabetes for less than one month to test new vaccine. (8 June 2003)
  242. Type 1 diabetes in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort modelling. (8 June 2003)
  243. Preliminary Results of ITN Multicenter Islet Transplant Trial Confirm Potential Patient Benefits, Underscore Steep Learning Curve. (8 June 2003)
  244. Regression of Microalbuminuria in Type 1 Diabetes. See also PubMed abstract. (8 June 2003)
  245. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. (8 June 2003)
  246. Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitus. (8 June 2003)
  247. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. (8 June 2003)
  248. Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus. (8 June 2003)
  249. Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children. (8 June 2003)
  250. Islet transplantation: where do we stand now? (8 June 2003)
  251. The use of non-heart-beating donors for isolated pancreatic islet transplantation. (8 June 2003)
  252. Genes expressed in the developing endocrine pancreas and their importance for stem cell and diabetes research. (8 June 2003)
  253. Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword. Also available in PDF format. (8 June 2003)
  254. The Deadly Sins and Diabetes explores the causes of the increase in type 2 diabetes. (8 June 2003)
  255. The double puzzle of diabetes. (8 June 2003)
  256. Formation of Advanced Glycosylation End Products and Oxidative Stress in Young Patients with Type 1 Diabetes. (1 June 2003)
  257. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. (1 June 2003)
  258. Revascularization limits effectiveness of islet transplants. (1 June 2003)
  259. Type 1 diabetes in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort modelling. (1 June 2003)
  260. Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial Infarction. (1 June 2003)
  261. The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. (1 June 2003)
  262. Medical-Surgical Teamwork Cures Severe Insulin Condition in Newborns. (1 June 2003)
  263. Efficacy of Edaravone, a Free Radical Scavenger, on Left Ventricular Function and Structure in Diabetes Mellitus. (1 June 2003)
  264. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. (Free registration required.) See also Diabetes traced to womb. (1 June 2003)
  265. Novel drugs for the treatment of type 2 diabetes. (1 June 2003)
  266. The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual beta-cell function and long-term metabolic control. (25 May 2003)
  267. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. (25 May 2003)
  268. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. (25 May 2003)
  269. The artificial pancreas. (25 May 2003)
  270. Inhaled Insulin Produces Antibodies, But No Adverse Effects Found After Two-Year Study. (25 May 2003)
  271. Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients. (25 May 2003)
  272. A paracetamol-pasta test for assessing gastric emptying in healthy and diabetic subjects. (25 May 2003)
  273. Validation of albumin determined in urine with the HemoCue point-of-care analyser. (25 May 2003)
  274. Glucose metabolism in relatives of type 1 diabetic patients with albuminuria. (25 May 2003)
  275. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. (25 May 2003)
  276. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. (25 May 2003)
  277. Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset. (25 May 2003)
  278. Islet transplantation, stem cells, and transfusion medicine. Free full text available as HTML and PDF. (18 May 2003)
  279. Marital status and family size of type 1 diabetic patients in a French cohort. (18 May 2003)
  280. Diagnostics and therapy of diabetic nephrology. (18 May 2003)
  281. Development of type 1 diabetes in wild bank voles associated with islet autoantibodies and the novel ljungan virus. (18 May 2003)
  282. Transdermal drug delivery of insulin with ultradeformable carriers. (18 May 2003)
  283. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. (18 May 2003)
  284. Diabetes in the young: a paediatric and epidemiological perspective. (11 May 2003)
  285. Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus. (11 May 2003)
  286. Poorly managed diabetes can lead to dementia. (11 May 2003)
  287. Phase II clinical trial demonstrates that Posurdex is highly effective in improving vision in patients with persistent macular edema, which can be caused by diabetic retinopathy. (11 May 2003)
  288. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. (11 May 2003)
  289. Naturally Occurring Protein Protects Human Islet Cells from Death. See also Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. (4 May 2003)
  290. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. (4 May 2003)
  291. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. (4 May 2003)
  292. Underutilization of pancreas donors. (4 May 2003)
  293. Small area variation in childhood diabetes mellitus in Austria: links to population density, 1989 to 1999. (4 May 2003)
  294. Bioethical theory and practice in genetic screening for type 1 diabetes. (4 May 2003)
  295. Reduced Frequency of HLA DRB1*03-DQB1*02 in Children with Type 1 Diabetes Associated with Enterovirus RNA. (4 May 2003)
  296. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings. (4 May 2003)
  297. Changes in lymphocyte subsets in children with newly diagnosed type 1 diabetes mellitus. (4 May 2003)
  298. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. See also Gene change causes diabetes. (4 May 2003)
  299. Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes: Reduced Awakening From Sleep During Hypoglycemia. (27 April 2003)
  300. Transfer of Insulin Lispro Across the Human Placenta concludes that "lispro is unlikely to reach or harm the unborn baby." (27 April 2003)
  301. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. (27 April 2003)
  302. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. (27 April 2003)
  303. From external to implantable insulin pump, can we close the loop? (27 April 2003)
  304. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. (27 April 2003)
  305. New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy. (27 April 2003)
  306. C-Reactive Protein and Glycemic Control in Adults With Diabetes. (27 April 2003)
  307. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects. (27 April 2003)
  308. Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects. (27 April 2003)
  309. Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy. (27 April 2003)
  310. Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes. (27 April 2003)
  311. Audit on Stillbirths in Women With Pregestational Type 1 Diabetes. (27 April 2003)
  312. A Low-Iron-Available, Polyphenol-Enriched, Carbohydrate-Restricted Diet to Slow Progression of Diabetic Nephropathy. (27 April 2003)
  313. Plasma Prekallikrein: A Risk Marker for Hypertension and Nephropathy in Type 1 Diabetes. (27 April 2003)
  314. Scientists Discover Unique Source of Postnatal Stem Cells. (27 April 2003)
  315. Eating disturbances in girls with diabetes: the contribution of adolescent self-concept, maternal weight and shape concerns and mother-daughter relationships. (20 April 2003)
  316. Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. See also full text as PDF file and PubMed abstract. (20 April 2003)
  317. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial (Finnish TRIGR Study Group). (20 April 2003)
  318. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure? (20 April 2003)
  319. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. (20 April 2003)
  320. Trends of childhood diabetes incidence in Slovakia 1985-2000: accelerated increase in the years 1990-2000. (20 April 2003)
  321. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. (20 April 2003)
  322. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. (20 April 2003)
  323. In Situ Evidence That Peripheral Insulin Resistance in Adolescents with Poorly Controlled Type 1 Diabetes Is Associated with Impaired Suppression of Lipolysis: A Microdialysis Study. (20 April 2003)
  324. Cause-specific and total mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population: a 15-year follow-up study. (20 April 2003)
  325. Pitt Researchers Develop Noninvasive Glucose Sensor. (See High Ionic Strength Glucose-Sensing Photonic Crystal to purchase access to the article.) (20 April 2003)
  326. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. See also Heart disease mortality higher in diabetic women than diabetic men. (20 April 2003)
  327. Protein in Wheat May Play Role in Promoting Diabetes. See also A Type 1 Diabetes-related Protein from Wheat (Triticum aestivum). (13 April 2003)
  328. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients. (13 April 2003)
  329. Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia. (13 April 2003)
  330. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. (13 April 2003)
  331. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. (13 April 2003)
  332. Novel Chemical Better Maintains Pancreatic Islet Cell Structure and Function During Freezing. See also New chemical better enables frozen islet cells to stay viable for transplant. (13 April 2003)
  333. Diabetes in the young: a paediatric and epidemiological perspective. (13 April 2003)
  334. Soluble adhesion molecules in pre-clinical Type 1 diabetes: a prospective study. (13 April 2003)
  335. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. (13 April 2003)
  336. Cell wars: As the debate over embryonic stem cell research intensifies, Florida scientists are fighting for their right to clone. (13 April 2003)
  337. Loss of brain tissue may contribute to cognitive impairment among healthy diabetes patients. See Cerebral Atrophy in Young, Otherwise Healthy Patients with Type I Diabetes Mellitus. (6 April 2003)
  338. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. (6 April 2003)
  339. China Succeeds in First Case of Pancreatic Cell Transplanting. (6 April 2003)
  340. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. Also in PDF format. See also the commentary, Bone marrow: An extra-pancreatic hideout for the elusive pancreatic stem cell? (6 April 2003)
  341. A test for adequacy of chromium nutrition in humans-relation to Type 2 diabetes mellitus. (6 April 2003)
  342. Predictors of hemoglobin a1c in a national sample of nondiabetic children: the third national health and nutrition examination survey, 1988-1994. (6 April 2003)
  343. Do All Prepubertal Years of Diabetes Duration Contribute Equally to Diabetes Complications? (30 March 2003)
  344. Absence of Adverse Effects of Severe Hypoglycemia on Cognitive Function in School-Aged Children With Diabetes Over 18 Months. (30 March 2003)
  345. Brief report: cross-cultural replication of an anomalous psychometric pattern in children with type 1 diabetes. (30 March 2003)
  346. Prediabetes in children: natural history, diagnosis, and preventive strategies. (30 March 2003)
  347. Promising Results for Islet Cell Transplantation to Treat Diabetes. (30 March 2003)
  348. Alginate microcapsules for pancreatic islet cell graft immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus. (30 March 2003)
  349. Breakthrough Treatment To Halt Or Prevent Diabetic Kidney Damage. (30 March 2003)
  350. Cole Eye Institute Researchers Discover Novel Mechanism Used To Prevent Abnormal Blood Vessel Growth. Future Work Will Focus on Discovery’s Potential to Treat Age-Related Macular Degeneration, Diabetic Retinopathy and Cancer. See also A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. (30 March 2003)
  351. Poor Prognosis of Young Adults With Type 1 Diabetes. (30 March 2003)
  352. Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes. (30 March 2003)
  353. Thyroid Dysfunction in Patients With Type 1 Diabetes. (30 March 2003)
  354. Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes. (30 March 2003)
  355. Menstrual Cycle Differences Between Women With Type 1 Diabetes and Women Without Diabetes. (30 March 2003)
  356. Effects of Postmenopausal Hormone Replacement Therapy on HbA1c Levels. (30 March 2003)
  357. Read the 2002 Annual Report of the Diabetes Research Institute. (1.75MB PDF) (23 March 2003)
  358. Pertussis infection in childhood and subsequent type 1 diabetes mellitus. (23 March 2003)
  359. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). (23 March 2003)
  360. Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes. (23 March 2003)
  361. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study. (23 March 2003)
  362. A simulation model for estimating direct costs of type 1 diabetes prevention. (23 March 2003)
  363. Insulin gene transfer enhances the function of human islet grafts. (23 March 2003)
  364. Acceleration of type 1 diabetes mellitus in proinsulin 2–deficient NOD mice. (23 March 2003)
  365. ACE inhibition salvages the visual loss caused by diabetes. (23 March 2003)
  366. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. (23 March 2003)
  367. Ultrasonography of plantar soft tissues thickness in young people with diabetes. (23 March 2003)
  368. Effect of Chronic Treatment with Vitamin E on Endothelial Dysfunction in a Type I in Vivo Diabetes Mellitus Model and in Vitro. (23 March 2003)
  369. Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. (23 March 2003)
  370. Loss of early insulin secretion leads to postprandial hyperglycaemia. (23 March 2003)
  371. Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassay. (23 March 2003)
  372. Pulmonary Insulin Delivery System Safe, Well Tolerated in Smokers and Asthmatics. (23 March 2003)
  373. Zeroing in on a Cure for Diabetes describes Ken Bernstein's experience receiving an islet transplant at the Diabetes Research Institute. (16 March 2003)
  374. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. (16 March 2003)
  375. Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN). (16 March 2003)
  376. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. (16 March 2003)
  377. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. (16 March 2003)
  378. Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes. (16 March 2003)
  379. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. (9 March 2003)
  380. Evaluation of the frequency of micro and macro vascular complications among a cohort of diabetic out-patients without proteinuria. (9 March 2003)
  381. Molecular aspects of type 1 diabetes . Also available in PDF format. (9 March 2003)
  382. Severe hypoglycemia in diabetics with impaired renal function. (9 March 2003)
  383. Clinical, metabolic, immunologic and genotypic characteristics in non-pediatric patients with type 1A diabetes mellitus. Onset and short-term prognosis. (9 March 2003)
  384. Stable alpha- and beta-Islet Cell Function After Tolerance Induction to Pancreatic Islet Allografts in Diabetic Primates. (9 March 2003)
  385. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. (9 March 2003)
  386. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (1534 yrs) in the Diabetes Incidence Study in Sweden (DISS). (9 March 2003)
  387. The Type 1 Diabetes Genetics Consortium (T1DGC) proposes to organize international efforts to identify genes that determine an individual's risk of type 1 diabetes. (9 March 2003)
  388. Leptin. Metabolic control and regulation. (9 March 2003)
  389. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. (2 March 2003)
  390. Autoimmune Islet Destruction in Spontaneous Type 1 Diabetes Is Not Beta-Cell Exclusive (free full text). (2 March 2003)
  391. Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects. (2 March 2003)
  392. The Impact of Smoking on Inhaled Insulin. (2 March 2003)
  393. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. (2 March 2003)
  394. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With alpha-Lipoic Acid. (2 March 2003)
  395. The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes. (2 March 2003)
  396. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. (2 March 2003)
  397. A Controlled Trial of Web-Based Diabetes Disease Management. (2 March 2003)
  398. Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes. (2 March 2003)
  399. The morphology of islets within the porcine donor pancreas determines the isolation result: successful isolation of pancreatic islets can now be achieved from young market pigs. (2 March 2003)
  400. Transarterial intrahepatic xenotransplantation of microencapsulated newborn porcine islets--an experimental study of type 1 diabetes mellitus. (23 February 2003)
  401. Experimental conversion of liver to pancreas. See also Gene-treated liver cells could help diabetics. (23 February 2003)
  402. University of Houston Researchers Focus On Diagnosing Eye Disease Using Adaptive Optics. (23 February 2003)
  403. von Willebrand Factor and Its Propeptide in Children with Diabetes. Relation between Endothelial Dysfunction and Microalbuminuria. (23 February 2003)
  404. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. (23 February 2003)
  405. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. (23 February 2003)
  406. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. (23 February 2003)
  407. Retinol and alpha-tocopherol in serum of type 1 diabetic patients with intensive insulin therapy. A long term follow-up study. (23 February 2003)
  408. Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension. (23 February 2003)
  409. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. (23 February 2003)
  410. The relationship between birth weight and maternal glycated haemoglobin (HbA1c) concentration in pregnancies complicated by Type 1 diabetes. (23 February 2003)
  411. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Full text is available free as HTML or PDF. (23 February 2003)
  412. A new look at viruses in type 1 diabetes. (23 February 2003)
  413. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. (23 February 2003)
  414. Childhood diabetes identified in mass urine screening program in Taiwan, 1993-1999. (23 February 2003)
  415. C-peptide and autoimmune markers in diabetes. (23 February 2003)
  416. The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus. (23 February 2003)
  417. Anti-Inflammatory Effects of alpha-Melanocyte-Stimulating Hormone in Celiac Intestinal Mucosa. See also Discovery may lead to first medical treatment for Celiac disease. (23 February 2003)
  418. Interactions between hypoglycemia and sleep architecture in children with type 1 diabetes mellitus. (16 February 2003)
  419. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state. (16 February 2003)
  420. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. (16 February 2003)
  421. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. (16 February 2003)
  422. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. (16 February 2003)
  423. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study. (16 February 2003)
  424. Glucose intolerance in children with cystic fibrosis. (16 February 2003)
  425. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. See also Largest study ever finds that one out of every 133 Americans may have celiac disease. (16 February 2003)
  426. Celiac disease often goes undiagnosed, study finds. (16 February 2003)
  427. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. (16 February 2003)
  428. Type 2 Diabetes mellitus in Children and Adolescents: A Review from a European Perspective. (16 February 2003)
  429. Association Between Regional Adipose Tissue Distribution and Both Type 2 Diabetes and Impaired Glucose Tolerance in Elderly Men and Women. See also Elderly people with normal weight also at risk of diabetes. (16 February 2003)
  430. A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. See also Ottawa researchers link Type 1 diabetes to wheat. (9 February 2003)
  431. High Blood Sugar Linked to Lost Memory. See also Side Effects: Jog Your Memory? At the Gym? (free registration required) (9 February 2003)
  432. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients. (2 February 2003)
  433. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. See also Vitamins C and E may enhance effectiveness of insulin for diabetes. (2 February 2003)
  434. New enzymatic assay for glycohemoglobin. (2 February 2003)
  435. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. See also Diabetes, heart risk linked to NZ milk. (26 January 2003)
  436. Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes. See also Young adults with insulin-treated diabetes have elevated stroke risk. (26 January 2003)
  437. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. (26 January 2003)
  438. Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes. (26 January 2003)
  439. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. See also Scientists find biomarkers in bloodstream indicating risk of Type 1 diabetes. (26 January 2003)
  440. Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. See also Autoantibody Positive Gestational Hyperglycaemic Women Need Insulin More Often. (26 January 2003)
  441. Prevention strategies for type 1 diabetes mellitus: current status and future directions. (26 January 2003)
  442. Simultaneous pancreas-kidney and pancreas transplantation. (26 January 2003)
  443. Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: a decision analysis of treatment options. (26 January 2003)
  444. Liver converted to pancreas. (26 January 2003)
  445. Enhancement of Endothelial Function by Pregnancy. (26 January 2003)
  446. The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes. (26 January 2003)
  447. A Prospective Study of Self-Reported Sleep Duration and Incident Diabetes in Women. (26 January 2003)
  448. Similar Genetic Features and Different Islet Cell Autoantibody Pattern of Latent Autoimmune Diabetes in Adults (LADA) Compared With Adult-Onset Type 1 Diabetes With Rapid Progression. (26 January 2003)
  449. Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes. See also Young adults with insulin-treated diabetes have elevated stroke risk. (19 January 2003)
  450. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). (19 January 2003)
  451. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. (19 January 2003)
  452. Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. (19 January 2003)
  453. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. (19 January 2003)
  454. Relationship between avoidable hospitalizations for diabetes mellitus and income level. (19 January 2003)
  455. Type 2 Diabetes Mellitus Among Florida Children and Adolescents, 1994 through 1998. (19 January 2003)
  456. Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children. (19 January 2003)
  457. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. (19 January 2003)
  458. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. (12 January 2003)
  459. Prediction of Severe Hypoglycaemia by Angiotensin-Converting Enzyme Activity and Genotype in Type 1 Diabetes. (12 January 2003)
  460. Effects of acute hypoglycaemia on auditory information processing in adults with Type I diabetes. (12 January 2003)
  461. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state. (12 January 2003)
  462. Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes. (12 January 2003)
  463. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. (12 January 2003)
  464. Diabetic Muscle Infarction: An underdiagnosed complication of long-standing diabetes. (12 January 2003)
  465. Determinants of Fetal Growth at Different Periods of Pregnancies Complicated by Gestational Diabetes Mellitus or Impaired Glucose Tolerance. (12 January 2003)
  466. Study finds thyroid dysfunction in 4.6% of children newly diagnosed with type 1 diabetes. (12 January 2003)
  467. Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. (12 January 2003)
  468. Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. (12 January 2003)
  469. Pancreatic Islet Transplantation Produced Insulin Independence In Type I Diabetics. (12 January 2003)
  470. Lowered Insulin Response May Herald Juvenile Diabetes. (12 January 2003)
  471. Parental diabetes and birth weight of offspring: intergenerational cohort study. Also in PDF format. (12 January 2003)
  472. Study At University of Iowa For Women With Type 1 Diabetes. (12 January 2003)
  473. Protein may Reduce Diabetic Complications. (12 January 2003)
  474. HHS Announces Research Plan To Fight Autoimmune Diseases. See also NIH Autoimmune Diseases Coordinating Committee - Autoimmune Diseases Research Plan. (12 January 2003)
  475. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. (12 January 2003)
  476. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. (12 January 2003)
  477. Diamyd Medical reports on its GAD vaccine for insulin-dependent diabetes. (12 January 2003)
  478. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. (12 January 2003)
  479. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. (5 January 2003)
  480. Acceptance, cognitions, and resourcefulness in women with diabetes. (5 January 2003)

[ Current Research News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:29:01
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.